LEGFLOW RX/OTW
Commercial- Indications
- Peripheral artery disease
Company intelligence / Profile preview
Cardionovum
Bonn, Nordrhein-Westfalen, Germanycardionovum.de ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Cardionovum is a pioneer in cardiovascular medical devices, notably introducing the world’s first CE-approved drug-eluting balloon catheter. Their portfolio includes clinically proven paclitaxel-releasing balloons and sirolimus-eluting stents for coronary and peripheral interventions. Clinical studies support their efficacy, especially for complex lesions, ISR, PAD, and hemodialysis shunt stenosis.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceDrug-eluting balloon catheterDrug-eluting stent
- Industry
- Surgical Medical Devices
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Cardionovum.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cardionovum.